Optical coherence tomography assessment of early stent strut coverage in patients treated with a thin-strut bare cobalt-chromium stent coated with silicon carbide

International Journal of Cardiology

Volumn 157, Issue 2, 2012, Pages 291-292

  Samim, Mariam ^a   Agostoni, Pierfrancesco ^a   Voskuil, Michiel ^a   Belkacemi, Anouar ^a   Doevendans, Pieter A ^a   Stella, Pieter R ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Bare metal stent; Endothelialisation; Optical coherence tomography

Indexed keywords

ACETYLSALICYLIC ACID; CHROMIUM; CLOPIDOGREL; COBALT; FIBRINOGEN RECEPTOR ANTAGONIST; SILICON CARBIDE;

ACUTE CORONARY SYNDROME; BALLOON DILATATION; BARE METAL STENT; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG ELUTING STENT; HUMAN; IN-STENT RESTENOSIS; INFLAMMATION; LETTER; NEOINTIMA; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STENT THROMBOSIS; THROMBOGENICITY; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 84861099764     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.126     Document Type: Article

References (10)

1. P.W. Serruys, M.C. Morice, and A.P. Kappetein SYNTAX Investigators. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease N Engl J Med 360 2009 961 972
2. M.A. Hlatky, D.B. Boothroyd, and D.M. Bravata Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials Lancet 373 2009 1190 1197
3. M. Vorpahl, R. Virmani, E. Ladich, and A.V. Finn Vascular remodeling after coronary stent implantation Minerva Cardioangiol 57 2009 621 628
4. A.V. Finn, G. Nakazawa, and M. Joner Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
5. S.H. Monnink, A.J. van Boven, and H.O. Peels Silicon-carbide coated coronary stents have low platelet and leukocyte adhesion during platelet activation J Investig Med 47 1999 304 310
6. A. Rzany, and M. Schaldach Smart material silicon carbide: reduced activation of cells and proteins on a-SiC:H-coated stainless steel Prog Biomed Res 6 2001 182 194
7. R. Virmani Drug-eluting stent substances - is there room for improvement? Lecture at EuroPCR 2007, Barcelona, Spain, 22-25 May 2007 2007 Available at: http://www.pcronline.com/Lectures/2007/Drug-eluting-stent-substances-is-there- room-for-improvements. Last access: 26 January 2011
8. A.J.S. Coats, and L.G. Shewan Statement on Authorship and Publishing Ethics in the International Journal of Cardiology Int J Cardiol 153 2011 239 240
9. M. Takano, S. Inami, and I.K. Jang Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation Am J Cardiol 99 2007 1033 1038
10. Y. Xie, M. Takano, and D. Murakami Comparison of neointimal coverage by optical coherence tomography of a sirolimus-eluting stent versus a bare-metal stent three months after implantation Am J Cardiol 102 2008 27 31